 | • レポートコード：GIR-107A12568 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ペット用医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペット用医薬品の種類別市場規模（駆虫薬、抗菌剤、その他）、用途別市場規模（犬、猫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ペット用医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Zoetis、Boehringer Ingelheim、Merck Animal Health、Elanco Animal Health、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Meiji、Ouro Fino Saude、Parnell ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：駆虫薬、抗菌剤、その他 ・用途別分析2016年-2026年：犬、猫、その他 ・ペット用医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ペット用医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペット用医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペット用医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ペット用医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pet Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pet Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pet Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pet Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Antiparasitic Drugs
Antibacterial
Other
Market segment by Application, can be divided into
Dogs
Cats
Other
Market segment by players, this report covers
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pet Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pet Drug, with revenue, gross margin and global market share of Pet Drug from 2019 to 2021.
Chapter 3, the Pet Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Pet Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Pet Drug research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Pet Drug
1.2 Classification of Pet Drug by Type
1.2.1 Overview: Global Pet Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pet Drug Revenue Market Share by Type in 2020
1.2.3 Antiparasitic Drugs
1.2.4 Antibacterial
1.2.5 Other
1.3 Global Pet Drug Market by Application
1.3.1 Overview: Global Pet Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Pet Drug Market Size & Forecast
1.5 Global Pet Drug Market Size and Forecast by Region
1.5.1 Global Pet Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pet Drug Market Size by Region, (2016-2021)
1.5.3 North America Pet Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Pet Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pet Drug Market Size and Prospect (2016-2026)
1.5.6 South America Pet Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pet Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pet Drug Market Drivers
1.6.2 Pet Drug Market Restraints
1.6.3 Pet Drug Trends Analysis
2 Company Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Pet Drug Product and Solutions
2.1.4 Zoetis Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Zoetis Recent Developments and Future Plans
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Pet Drug Product and Solutions
2.2.4 Boehringer Ingelheim Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
2.3 Merck Animal Health
2.3.1 Merck Animal Health Details
2.3.2 Merck Animal Health Major Business
2.3.3 Merck Animal Health Pet Drug Product and Solutions
2.3.4 Merck Animal Health Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Animal Health Recent Developments and Future Plans
2.4 Elanco Animal Health
2.4.1 Elanco Animal Health Details
2.4.2 Elanco Animal Health Major Business
2.4.3 Elanco Animal Health Pet Drug Product and Solutions
2.4.4 Elanco Animal Health Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Elanco Animal Health Recent Developments and Future Plans
2.5 Virbac
2.5.1 Virbac Details
2.5.2 Virbac Major Business
2.5.3 Virbac Pet Drug Product and Solutions
2.5.4 Virbac Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Virbac Recent Developments and Future Plans
2.6 Dechra Veterinary Products
2.6.1 Dechra Veterinary Products Details
2.6.2 Dechra Veterinary Products Major Business
2.6.3 Dechra Veterinary Products Pet Drug Product and Solutions
2.6.4 Dechra Veterinary Products Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Dechra Veterinary Products Recent Developments and Future Plans
2.7 Ceva
2.7.1 Ceva Details
2.7.2 Ceva Major Business
2.7.3 Ceva Pet Drug Product and Solutions
2.7.4 Ceva Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Ceva Recent Developments and Future Plans
2.8 Vetoquinol
2.8.1 Vetoquinol Details
2.8.2 Vetoquinol Major Business
2.8.3 Vetoquinol Pet Drug Product and Solutions
2.8.4 Vetoquinol Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Vetoquinol Recent Developments and Future Plans
2.9 Meiji
2.9.1 Meiji Details
2.9.2 Meiji Major Business
2.9.3 Meiji Pet Drug Product and Solutions
2.9.4 Meiji Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Meiji Recent Developments and Future Plans
2.10 Ouro Fino Saude
2.10.1 Ouro Fino Saude Details
2.10.2 Ouro Fino Saude Major Business
2.10.3 Ouro Fino Saude Pet Drug Product and Solutions
2.10.4 Ouro Fino Saude Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Ouro Fino Saude Recent Developments and Future Plans
2.11 Parnell
2.11.1 Parnell Details
2.11.2 Parnell Major Business
2.11.3 Parnell Pet Drug Product and Solutions
2.11.4 Parnell Pet Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Parnell Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pet Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pet Drug Players Market Share
3.2.2 Top 10 Pet Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Pet Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pet Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Pet Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pet Drug Revenue Market Share by Application (2016-2021)
5.2 Pet Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pet Drug Revenue by Type (2016-2026)
6.2 North America Pet Drug Revenue by Application (2016-2026)
6.3 North America Pet Drug Market Size by Country
6.3.1 North America Pet Drug Revenue by Country (2016-2026)
6.3.2 United States Pet Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Pet Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Pet Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pet Drug Revenue by Type (2016-2026)
7.2 Europe Pet Drug Revenue by Application (2016-2026)
7.3 Europe Pet Drug Market Size by Country
7.3.1 Europe Pet Drug Revenue by Country (2016-2026)
7.3.2 Germany Pet Drug Market Size and Forecast (2016-2026)
7.3.3 France Pet Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pet Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Pet Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Pet Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pet Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Pet Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Pet Drug Market Size by Region
8.3.1 Asia-Pacific Pet Drug Revenue by Region (2016-2026)
8.3.2 China Pet Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Pet Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Pet Drug Market Size and Forecast (2016-2026)
8.3.5 India Pet Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pet Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Pet Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pet Drug Revenue by Type (2016-2026)
9.2 South America Pet Drug Revenue by Application (2016-2026)
9.3 South America Pet Drug Market Size by Country
9.3.1 South America Pet Drug Revenue by Country (2016-2026)
9.3.2 Brazil Pet Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Pet Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pet Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Pet Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Pet Drug Market Size by Country
10.3.1 Middle East & Africa Pet Drug Revenue by Country (2016-2026)
10.3.2 Turkey Pet Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pet Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Pet Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Pet Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pet Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pet Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pet Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pet Drug Revenue Market Share by Region (2021-2026)
Table 6. Zoetis Corporate Information, Head Office, and Major Competitors
Table 7. Zoetis Major Business
Table 8. Zoetis Pet Drug Product and Solutions
Table 9. Zoetis Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Pet Drug Product and Solutions
Table 13. Boehringer Ingelheim Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Animal Health Corporate Information, Head Office, and Major Competitors
Table 15. Merck Animal Health Major Business
Table 16. Merck Animal Health Pet Drug Product and Solutions
Table 17. Merck Animal Health Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Elanco Animal Health Corporate Information, Head Office, and Major Competitors
Table 19. Elanco Animal Health Major Business
Table 20. Elanco Animal Health Pet Drug Product and Solutions
Table 21. Elanco Animal Health Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Virbac Corporate Information, Head Office, and Major Competitors
Table 23. Virbac Major Business
Table 24. Virbac Pet Drug Product and Solutions
Table 25. Virbac Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Dechra Veterinary Products Corporate Information, Head Office, and Major Competitors
Table 27. Dechra Veterinary Products Major Business
Table 28. Dechra Veterinary Products Pet Drug Product and Solutions
Table 29. Dechra Veterinary Products Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Ceva Corporate Information, Head Office, and Major Competitors
Table 31. Ceva Major Business
Table 32. Ceva Pet Drug Product and Solutions
Table 33. Ceva Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Vetoquinol Corporate Information, Head Office, and Major Competitors
Table 35. Vetoquinol Major Business
Table 36. Vetoquinol Pet Drug Product and Solutions
Table 37. Vetoquinol Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Meiji Corporate Information, Head Office, and Major Competitors
Table 39. Meiji Major Business
Table 40. Meiji Pet Drug Product and Solutions
Table 41. Meiji Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Ouro Fino Saude Corporate Information, Head Office, and Major Competitors
Table 43. Ouro Fino Saude Major Business
Table 44. Ouro Fino Saude Pet Drug Product and Solutions
Table 45. Ouro Fino Saude Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Parnell Corporate Information, Head Office, and Major Competitors
Table 47. Parnell Major Business
Table 48. Parnell Pet Drug Product and Solutions
Table 49. Parnell Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Pet Drug Revenue (USD Million) by Players (2019-2021)
Table 51. Global Pet Drug Revenue Share by Players (2019-2021)
Table 52. Breakdown of Pet Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Pet Drug Players Head Office, Products and Services Provided
Table 54. Pet Drug Mergers & Acquisitions in the Past Five Years
Table 55. Pet Drug New Entrants and Expansion Plans
Table 56. Global Pet Drug Revenue (USD Million) by Type (2016-2021)
Table 57. Global Pet Drug Revenue Share by Type (2016-2021)
Table 58. Global Pet Drug Revenue Forecast by Type (2021-2026)
Table 59. Global Pet Drug Revenue by Application (2016-2021)
Table 60. Global Pet Drug Revenue Forecast by Application (2021-2026)
Table 61. North America Pet Drug Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Pet Drug Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Pet Drug Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Pet Drug Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Pet Drug Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Pet Drug Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Pet Drug Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Pet Drug Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Pet Drug Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Pet Drug Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Pet Drug Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Pet Drug Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Pet Drug Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Pet Drug Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Pet Drug Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Pet Drug Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Pet Drug Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Pet Drug Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Pet Drug Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Pet Drug Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Pet Drug Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Pet Drug Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Pet Drug Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Pet Drug Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Pet Drug Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Pet Drug Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Pet Drug Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Pet Drug Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Pet Drug Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Pet Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pet Drug Picture
Figure 2. Global Pet Drug Revenue Market Share by Type in 2020
Figure 3. Antiparasitic Drugs
Figure 4. Antibacterial
Figure 5. Other
Figure 6. Pet Drug Revenue Market Share by Application in 2020
Figure 7. Dogs Picture
Figure 8. Cats Picture
Figure 9. Other Picture
Figure 10. Global Pet Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Pet Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Pet Drug Revenue Market Share by Region (2016-2026)
Figure 13. Global Pet Drug Revenue Market Share by Region in 2020
Figure 14. North America Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Pet Drug Market Drivers
Figure 20. Pet Drug Market Restraints
Figure 21. Pet Drug Market Trends
Figure 22. Zoetis Recent Developments and Future Plans
Figure 23. Boehringer Ingelheim Recent Developments and Future Plans
Figure 24. Merck Animal Health Recent Developments and Future Plans
Figure 25. Elanco Animal Health Recent Developments and Future Plans
Figure 26. Virbac Recent Developments and Future Plans
Figure 27. Dechra Veterinary Products Recent Developments and Future Plans
Figure 28. Ceva Recent Developments and Future Plans
Figure 29. Vetoquinol Recent Developments and Future Plans
Figure 30. Meiji Recent Developments and Future Plans
Figure 31. Ouro Fino Saude Recent Developments and Future Plans
Figure 32. Parnell Recent Developments and Future Plans
Figure 33. Global Pet Drug Revenue Share by Players in 2020
Figure 34. Pet Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Pet Drug Revenue Market Share in 2020
Figure 36. Global Top 10 Players Pet Drug Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Pet Drug Revenue Share by Type in 2020
Figure 39. Global Pet Drug Market Share Forecast by Type (2021-2026)
Figure 40. Global Pet Drug Revenue Share by Application in 2020
Figure 41. Global Pet Drug Market Share Forecast by Application (2021-2026)
Figure 42. North America Pet Drug Sales Market Share by Type (2016-2026)
Figure 43. North America Pet Drug Sales Market Share by Application (2016-2026)
Figure 44. North America Pet Drug Revenue Market Share by Country (2016-2026)
Figure 45. United States Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Pet Drug Sales Market Share by Type (2016-2026)
Figure 49. Europe Pet Drug Sales Market Share by Application (2016-2026)
Figure 50. Europe Pet Drug Revenue Market Share by Country (2016-2026)
Figure 51. Germany Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Pet Drug Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Pet Drug Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Pet Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Pet Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Pet Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Pet Drug Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Pet Drug Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Pet Drug Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Pet Drug Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の甲状腺機能低下症治療薬市場 2021：企業別、地域別、種類・用途別 The Hypothyroidism Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界の薬物乱用検査サービス市場 2021：企業別、地域別、種類・用途別 The Drug of Abuse Testing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のNSCLC用標的薬HER2阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug HER2 Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の腸内細菌科感染症薬市場 2021：企業別、地域別、種類・用途別 The Enterobacteriaceae Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界の化学療法薬市場 2021：企業別、地域別、種類・用途別 The Chemotherapy Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …